Audit MicroControls Linearity LQ Cystatin-C
Single (Specified) Analyte Controls (Assayed And Unassayed). 510(k) K143571, from Aalto Scientific, Ltd. (Carlsbad, CA). Product code JJX, class 1.
As of Nov 20, 2026, K143571 is an FDA 510(k) held by Aalto Scientific, Ltd., substantially equivalent on Jan 23, 2015 after 37 days, with no recalls tied to it in FDA's recall database.
- Review time: 37 days
- Recalls: 0
The Linearity LQ Cystatin-C is an assayed quality control material intended to simulate human patient samples for use in determining linearity, calibration verification, and the verification of reportable range for the Cystatin-C analyte. The Linearity LQ Cystatin-C is for In Vitro Diagnostic use only.
- Audit Microcv Beta-Hydroxybutyric Acid Linearity SetK130157 · Aalto Scientific, Ltd. · Mar 19, 2013
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Dec 17, 2014
- Review panel
- Clinical Chemistry
- Regulation
- 21 CFR 862.1660
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files